Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Pemov

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Cancer|February 15, 2017
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentationRamita Dewan, Alexander Pemov, Amalia S Dutra, et al.
Human Genetics|May 6, 2015
Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large familyAnand Pathak, Alexander Pemov, Mary L McMaster, et al.
Haematologica|January 2, 2016
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large familyAnand Pathak, Katja Seipel, Alexander Pemov, et al.
Cancer Research|September 10, 2009
Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel associationHilde Brems, Caroline Park, Ophélia Maertens, et al.
Plos Genetics|October 21, 2014
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysisAlexander Pemov, Heejong Sung, Paula L Hyland, et al.
Neuro-Oncology|February 6, 2019
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromasAlexander Pemov, Nancy F Hansen, Sivasish Sindiri, et al.
Plos One|March 10, 2026
Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromasHua Li, Alexander Pemov, Robert Allaway, et al.
Plos One|January 21, 2026
Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromasHua Li, Alexander Pemov, Robert Allaway, et al.
JCO Precision Oncology|December 29, 2021
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing StudyAlexander Pemov, Talia Wegman-Ostrosky, Jung Kim, et al.
JNCI Cancer Spectrum|July 26, 2021
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor StudyJung Kim, Matthew Gianferante, Danielle M Karyadi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Cancer|February 15, 2017
First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentationRamita Dewan, Alexander Pemov, Amalia S Dutra, et al.
Human Genetics|May 6, 2015
Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large familyAnand Pathak, Alexander Pemov, Mary L McMaster, et al.
Haematologica|January 2, 2016
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large familyAnand Pathak, Katja Seipel, Alexander Pemov, et al.
Cancer Research|September 10, 2009
Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel associationHilde Brems, Caroline Park, Ophélia Maertens, et al.
Plos Genetics|October 21, 2014
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysisAlexander Pemov, Heejong Sung, Paula L Hyland, et al.
Neuro-Oncology|February 6, 2019
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromasAlexander Pemov, Nancy F Hansen, Sivasish Sindiri, et al.
Plos One|March 10, 2026
Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromasHua Li, Alexander Pemov, Robert Allaway, et al.
Plos One|January 21, 2026
Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromasHua Li, Alexander Pemov, Robert Allaway, et al.
JCO Precision Oncology|December 29, 2021
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing StudyAlexander Pemov, Talia Wegman-Ostrosky, Jung Kim, et al.
JNCI Cancer Spectrum|July 26, 2021
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor StudyJung Kim, Matthew Gianferante, Danielle M Karyadi, et al.
Pageof 3